<VariationArchive RecordType="classified" VariationID="30026" VariationName="NM_021728.4(OTX2):c.245_260del (p.Lys82fs)" VariationType="Deletion" Accession="VCV000030026" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38981" VariationID="30026">
      <GeneList>
        <Gene Symbol="OTX2" FullName="orthodenticle homeobox 2" GeneID="5015" HGNC_ID="HGNC:8522" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="56799905" stop="56810479" display_start="56799905" display_stop="56810479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="57267424" stop="57277193" display_start="57267424" display_stop="57277193" Strand="-" />
          </Location>
          <OMIM>600037</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OTX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=OTX2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_021728.4(OTX2):c.245_260del (p.Lys82fs)</Name>
      <CanonicalSPDI>NC_000014.9:56804200:TCGGGCAAGTTGATTTTC:TC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="56804201" stop="56804216" display_start="56804201" display_stop="56804216" variantLength="16" positionVCF="56804200" referenceAlleleVCF="CTCGGGCAAGTTGATTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="57270919" stop="57270934" display_start="57270919" display_stop="57270934" variantLength="16" positionVCF="57270918" referenceAlleleVCF="CTCGGGCAAGTTGATTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K82fs</ProteinChange>
      <ProteinChange>K74fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_718t1" sequenceAccession="LRG_718t1">
            <Expression>LRG_718t1:c.245_260del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_718p1" sequenceAccession="LRG_718p1" change="p.Lys82fs">
            <Expression>LRG_718p1:p.Lys82fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.57270921_57270936del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.57270921_57270936del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.56804203_56804218del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.56804203_56804218del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008204.1" sequenceAccession="NG_008204" sequenceVersion="1" change="g.11251_11266del">
            <Expression>NG_008204.1:g.11251_11266del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270523.2" sequenceAccession="NM_001270523" sequenceVersion="2" change="c.221_236del">
            <Expression>NM_001270523.2:c.221_236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257452.1" sequenceAccession="NP_001257452" sequenceVersion="1" change="p.Lys74fs">
            <Expression>NP_001257452.1:p.Lys74fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270524.2" sequenceAccession="NM_001270524" sequenceVersion="2" change="c.221_236del">
            <Expression>NM_001270524.2:c.221_236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257453.1" sequenceAccession="NP_001257453" sequenceVersion="1" change="p.Lys74fs">
            <Expression>NP_001257453.1:p.Lys74fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270525.2" sequenceAccession="NM_001270525" sequenceVersion="2" change="c.245_260del">
            <Expression>NM_001270525.2:c.245_260del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257454.1" sequenceAccession="NP_001257454" sequenceVersion="1" change="p.Lys82fs">
            <Expression>NP_001257454.1:p.Lys82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021728.4" sequenceAccession="NM_021728" sequenceVersion="4" change="c.245_260del" MANESelect="true">
            <Expression>NM_021728.4:c.245_260del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_068374.1" sequenceAccession="NP_068374" sequenceVersion="1" change="p.Lys82fs">
            <Expression>NP_068374.1:p.Lys82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172337.3" sequenceAccession="NM_172337" sequenceVersion="3" change="c.221_236del">
            <Expression>NM_172337.3:c.221_236del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_758840.1" sequenceAccession="NP_758840" sequenceVersion="1" change="p.Lys74fs">
            <Expression>NP_758840.1:p.Lys74fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600037.0009" DB="OMIM" />
        <XRef Type="rs" ID="1566624472" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_021728.4(OTX2):c.245_260del (p.Lys82fs) AND Syndromic microphthalmia type 5" Accession="RCV000022926" Version="4">
        <ClassifiedConditionList TraitSetID="2610">
          <ClassifiedCondition DB="MedGen" ID="C1864690">Syndromic microphthalmia type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19965921</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2610" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2946" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RETINAL DYSTROPHY, EARLY-ONSET, WITH PITUITARY DYSFUNCTION</ElementValue>
                <XRef Type="Allelic variant" ID="600037.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINAL DYSTROPHY, EARLY-ONSET, WITHOUT PITUITARY DYSFUNCTION</ElementValue>
                <XRef Type="Allelic variant" ID="600037.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Syndromic microphthalmia type 5</ElementValue>
                <XRef ID="MONDO:0012413" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OTX2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS5</ElementValue>
                <XRef Type="MIM" ID="610125" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3692" />
                <XRef ID="3692" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="178364" DB="Orphanet" />
              <XRef ID="C1864690" DB="MedGen" />
              <XRef ID="MONDO:0012413" DB="MONDO" />
              <XRef Type="MIM" ID="610125" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49473" SubmissionDate="2011-05-20" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600037.0009_MICROPHTHALMIA, SYNDROMIC 5" title="OTX2, 16-BP DEL, NT221_MICROPHTHALMIA, SYNDROMIC 5" />
        <ClinVarAccession Accession="SCV000044217" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old boy with right clinical anophthalmia and left microphthalmia, who had developmental delay, short stature, and growth hormone deficiency (MCOPS5; 610125), Dateki et al. (2010) identified heterozygosity for a de novo 16-bp deletion (221_236del) in exon 4 of the OTX2 gene, predicted to cause a frameshift and premature termination codon. The deletion was not found in the unaffected parents or in 100 controls. Functional analysis revealed that the mutant protein had no transactivation functions for 4 promoters that were transactivated by wildtype OTX2; no dominant-negative effect was observed. Brain MRI revealed pituitary hypoplasia and ectopic posterior pituitary. The patient also had right-sided retractile testis.</Attribute>
              <Citation>
                <ID Source="PubMed">19965921</ID>
              </Citation>
              <XRef DB="OMIM" ID="610125" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="OTX2" />
          </GeneList>
          <Name>OTX2, 16-BP DEL, NT221</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">16-BP DEL, NT221</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600037.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MICROPHTHALMIA, SYNDROMIC 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49473" TraitType="Disease" MappingType="Name" MappingValue="MICROPHTHALMIA, SYNDROMIC 5" MappingRef="Preferred">
        <MedGen CUI="C1864690" Name="Syndromic microphthalmia type 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

